No menu items!
Friday, April 4, 2025

Cancer Institute

DBT-NII Receives Trademark for India’s First Indigenous Tumour Antigen SPAG9

ASPAGNIITM is being used in dendritic cell (DC) based immunotherapy in cervical, ovarian cancer and will also be used in breast cancer. ASPAGNIITM may revolutionise cancer treatment Cancer kills 8.51 lakh people in India every year (International Agency for Research on...
- Advertisement -spot_img

Latest News

MahaCollab Unites Stakeholders for Circular Textiles

The World Trade Center (WTC) Mumbai, All India Association of Industries (AIAI), and Tisser Artisans Trust jointly hosted ‘MahaCollab,’...
- Advertisement -spot_img